Changing scenario globally in view of trade tensions have brought certain stocks in focus. ASX listed companies have some stocks which are increasingly becoming attractive.
Australian Strategic Materials Ltd (ASX: ASM)
Australian Strategic Materials Ltd (ASX: ASM) is well placed to address the global need for secure and independent supply chains in rare earth elements (REE) amid increasing geopolitical tensions. Recent Chinese export restrictions on key REEs have highlighted the risks of overreliance on a single country. The company has long prepared for such disruptions through its vertically integrated “mine to metals” strategy. This contains the development of its operational Korean Metals Plant (KMP) and the Dubbo Project in New South Wales. These facilities provide a reliable alternative source for critical minerals, including neodymium, praseodymium, dysprosium, and terbium.
The Dubbo Project is a shovel ready, long-life resource with a wide range of strategic materials such as zirconium, niobium, and hafnium, in addition to rare earths. It is planned to be in production by 2028, pending funding.
The company Korean Metals Plant enhances this strategy by producing commercial quantities of rare earth metals and alloys, including NdPr metal and NdFeB alloy. The facility is also progressing toward commercial scale production by 2025. During the recent half year period ending 31 December 2024, the company validated its products with multiple new customers in Korea and the EU and completed sales of NdPr metal. The plant also engaged with suppliers in the EU and US to diversify feedstock sources and initiated discussions with stakeholders in Vietnam to explore further integration into the rare earth supply chain.
ASM continue to pursue innovation and operational progress while maintaining disciplined financial management and a strong commitment to environmental, social, and governance principles. Recent achievements include securing federal grant funding for feasibility assessments, completing several infrastructure and geotechnical studies, and advancing testwork on additional resource options through a partnership with Caspin Resources. These initiatives support ASM’s goal of reducing capital requirements and shortening implementation timelines for rare earth production. Through its mine to metals model, global funding support, and scalable metallisation capabilities, ASM is building a sustainable business positioned to meet growing global demand for critical materials essential to future technologies.
Singular Health Group Ltd (ASX: SHG)
Singular Health Group Limited (ASX: SHG), on 16 April 2025 declared their Quarterly Activities Report for the period ended 31 march 2025.
During the March 2025 quarter, Singular Health achieved key growth in its strategic collaboration with U.S.-based Provider Network Solution. The company successfully completed Phase 1 of their Memorandum of Understanding, which involved proving that its 3Dicom platform could securely access and interact with different hospital imaging systems. The platform’s ability to retrieve and analyse imaging data, as well as its potential to reduce redundant imaging and improve outcomes, was validated. This led to an accelerated transition into Phase 2, where both parties are now shaping the technical and commercial plans for a paid pilot program. Discussions are also underway to form a broader partnership aimed at rolling out the technology across U.S. Managed Service Organisations, with a goal to create a commercial database of medical imaging data.
The company is one of the best growth stocks to buy now, having finalized its 3Dicom Gateway, a web-based tool that supports real-time access to imaging data across different Picture Archiving and Communication Systems. This development makes the platform accessible through any browser without needing system specific infrastructure. Feedback from healthcare professionals was incorporated to refine the interface, workflows, and user experience. These efforts were aimed at ensuring the system fits naturally into clinical environments, improves ease of use, and enhances adoption across varied medical settings. The platform’s flexibility and usability remain core to ongoing development efforts.
SHG strengthened its position with over $965,000 in new funds from both cornerstone investments and option exercises. This boost in cash reserves supports preparations for the U.S. pilot launch, expected in the June quarter. Through a lean operational structure and growing investor interest, the company is prepared to advance its international commercial goals and drive broader adoption of its medical imaging solutions.
(Source: Company Announcements)
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.
